Tech Company Financing Transactions
Redwood Bioscience Funding Round
Takeda Ventures invested in a capital raise for Redwood Bioscience. The round was announced by the company on 4/23/2013.
Transaction Overview
Company Name
Announced On
4/23/2013
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
This funding will be applied to advancing Redwood's site specific protein modification technology for enhancing antibody-drug conjugates and peptide therapeutics.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5703 Hollis St.
Emeryville, CA 94608
USA
Emeryville, CA 94608
USA
Phone
Website
Email Address
Overview
Redwood Bioscience is developing a precision protein-chemical engineering technology to produce the next-generation of antibody-drug conjugates and other semi-synthetic biotherapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Gordon Foulkes
Chief Executive Officer
Karen Boezi
Chief Scientific Officer
David Rabuka
VP - Operations
Mike Blank
Browse more venture capital transactions:
Prev: 4/23/2013: Traitify venture capital transaction
Next: 4/23/2013: GroundMetrics venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to document every notable VC transaction. All VC database entries reported here are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs